TY  - GEN
AU  - Morley,N J
AU  - Marks,D I
TI  - Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia
SN  - 1744-8328
PY  - 2016///0929
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - Humans
KW  - Inotuzumab Ozogamicin
KW  - Molecular Targeted Therapy
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Recurrence
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1586/14737140.2016.1131614
ER  -